Angel Nguyen, PA
Surgical · Vancouver, WANPI 1912597410
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medical Device Business Services, Inc. at 59.4% of the total. Reporting peaked in 2024 at $1,218 and has fallen 84.5% since, to $189 in 2025.
Across 22 payments — averaging $98.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Si-bone, Inc.$373
- Johnson & Johnson$213
- Vertex$125
- Davol Inc.$106
- Solventum Corporation$64
What the payments were for
- Travel & lodging$99946%
- Food & beverage$1,05048%
- Education$1236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $1,290 |
| Si-bone, Inc. | 5 | $373 |
| Johnson & Johnson | 4 | $213 |
| Vertex | 1 | $125 |
| Davol Inc. | 1 | $106 |
| Solventum Corporation | 1 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATAFIX$1,126
- iFuse Implant$271
- SURGIFLO Hemostatic Matrix$127
- JOURNAVX$125
- ARISTA AH FLEXITIP$106
How this compares
$2,171 in reported general payments places this provider in the 85th percentile of 404 surgical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $4,443 |
| Celecoxib | 172 | $3,177 |
| Oxycodone Hcl | 197 | $967 |
| Hydromorphone Hcl | 93 | $542 |
| Ondansetron OdtOndansetron | 98 | $477 |
| Omeprazole | 60 | $315 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $205 |
| Cephalexin | 94 | $188 |
| Dexamethasone | 41 | $138 |
| Mupirocin | 13 | $101 |
| Meloxicam | 30 | $81 |
| Pantoprazole Sodium | 15 | $80 |
| Tramadol Hcl | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other surgical in Vancouver
- Vivian ChanVancouver$5K
- Nathan AmbroseVancouver$2K
- Gretchen ThornerYakima$612K
- Jana FlenerRenton$93K
- Jeffrey StepanianKirkland$52K
- Jin Lo TomblinSpokane$21K
- Philip HujdicRenton$17K
- Mark MashitaEverett$16K
- Lee Or RutenbergSeattle$13K
- Wesley SumrallBremerton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.